Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
Acceleron Pharma is a clinical-stage biopharmaceutical company.
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Seres Therapeutics is a microbiome therapeutics platform company which engages in developing biological drugs.
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.